共 50 条
Oligomeric Proanthocyanidin Complexes (OPC) Exert Anti-Proliferative and Pro-Apoptotic Effects on Prostate Cancer Cells
被引:22
|作者:
Neuwirt, Hannes
[1
]
Arias, Mercedes Cedeno
[1
]
Puhr, Martin
[1
]
Hobisch, Alfred
[2
]
Culig, Zoran
[1
]
机构:
[1] Innsbruck Med Univ, Dept Urol, A-6020 Innsbruck, Austria
[2] Gen Hosp Feldkirch, Dept Urol, Feldkirch, Austria
来源:
基金:
奥地利科学基金会;
关键词:
prostate tumors;
growth;
grape seeds;
maritime pine bark;
chemoprevention;
D O I:
10.1002/pros.20829
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUND. Oligomeric proanthocyanidin complexes (OPC) are extracted from grape seeds or maritime pine bark and have been used for enhancement of capillary stability and lymphatic drainage. Since a role for OPC in cancer prevention was postulated, we asked whether they have an effect on prostate cancer cells. METHODS. Cell proliferation was determined by 3 H-thymidine assay and cell cycle status was analyzed on a flow cytometer. Expression of regulators of proliferation and apoptosis was determined by Western blot. RESULTS. We found that androgen-responsive cells LNCaP are more sensitive to OPC in terms of inhibition of proliferation in comparison to androgen receptor-negative PC3 or DU145 cells. Treatment with OPC resulted in a decrease in the percentage of LNCaP cells in the S phase and an increase in the percentage of cells in sub G1 phase. The anti-proliferative and proapoptotic effect of OPC in the LNCaP cell line was associated with down-regulation of expression of the androgen receptor. Interestingly, similar regulatory effects of OPC, such as inhibition of expression of cyclin-dependent kinases and cyclins and stimulation of tumor suppressors p21 and p27, were seen in LNCaP and PC3 cells. Favorable changes in the Bcl-2/Bax ratio were observed in LNCaP and PC3 cells after the treatment with OPC. OPC caused an increase of phosphorylated mitogen-activated protein kinase p44 and p42, thus suggesting induction of cellular differentiation. CONCLUSIONS. We conclude that OPC is a candidate that fulfills criteria for chemopreventive strategies in prostate cancer that might be established in following in vivo studies. Prostate 68: 1647-1654, 2008. (C) 2008 Wiley- Liss, Inc.
引用
收藏
页码:1647 / 1654
页数:8
相关论文